Furthermore, in the presence of the PTPN2 variant, distinct alterations of the mucosa-associated gut microbiome were detected in IBD patients, suggesting an interplay of genetic risk factors, intestinal microbiota, and disease course [21]. The gene discussed is PTPN2; the disease is irritable bowel syndrome.